Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2026)

Monte Rosa Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.01 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 98.11% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 98.11% YoY), while the FY2025 annual figure was 0.28, up 36.83% from the prior year.
• Asset Utilization Ratio was 0.01 for Q1 2026 at Monte Rosa Therapeutics, down from 0.38 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.47 in Q2 2025 to a low of 0.0 in Q1 2024.
• Historically, Asset Utilization Ratio has averaged 0.21 across 3 years, with a median of 0.2 in 2024.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio surged 10179.04% in 2025, then sank 98.11% in 2026.
• A 3-year view of Asset Utilization Ratio shows it stood at 0.2 in 2024, then surged by 88.23% to 0.38 in 2025, then sank by 98.08% to 0.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.38 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.